Back

ResearchAndMarkets adds non-melanoma skin cancer market report through 2035

Verifying
  • ResearchAndMarkets.com added a report covering the NMSC market from 2025 to 2035.
  • North America holds 58% of the market, with a U.S. ASIR of 367 per 100,000.
  • FDA approved expanded Libtayo use after surgery and radiation for adults with CSCC.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.